Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care (NCT05910840)
Support-t, an Online Training and Peer Support Platform to Accompany Youth Living With Type 1 Diabetes Transitioning to Adult Healthcare
🩺 Plain-English Summary (8th-Grade Level)
The investigators will conduct a randomized controlled trial (RCT) to examine how an online training and peer support platform could help the preparation to transition to adult care. Among 14-16 year old youth with Type 1 Diabetes (T1D), the investigators aim to assess the effect of an online training and peer support platform (Support-t) integrated in usual care, compared with usual care on Hemoglobin A1c (HbA1c), adverse outcomes and psychosocial measures during the preparation for transition to adult care. The investigators will conduct a multi-site, parallel group, blinded (outcome assessors, data analysts), superiority RCT of adolescents with T1D (14-16 years of age) followed at one of 4 university teaching hospital-based pediatric diabetes clinics in the province of Quebec.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (6 items) and avoid the listed exclusions (3 items).
Location: Clinique de pédiatrie Le Copain-Hôpital de Gatineau — Gatineau
Age range: 14 Years to 16 Years
🧪 Interventions in This Study
- Support-t (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Severe neurocognitive disabilities
- Patients with conditions associated with shortened erythrocyte survival, such as hemolytic anemia or other conditions associated with inaccurate HbA1c
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (4 Sites)
- Clinique de pédiatrie Le Copain-Hôpital de Gatineau — Gatineau,
- Montreal Children's Hospital - McGill University Health Centre — Montreal,
- Centre Hospitalier Universitaire de Québec — Québec,
- Centre Hospitalier Universitaire de Sherbrooke — Sherbrooke,
📞 Contact the Study Coordinator
Phone: (514) 398-7848
Email: anne-sophie.brazeau@mcgill.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Diabetes Mellitus
- Early Tracking of Childhood Health Determinants (ETCHED) Study — Phoenix, Arizona
- Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature — Escondido, California
- Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People — Emo, Ontario
- Effectiveness of an Inpatient Rehabilitation and Prosthetic Training Model in Patients With Vascular and Metabolic Transfemoral Amputation — Mexico City, Mexico City
- The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes — Boston, Massachusetts
Explore by condition: All Diabetes Mellitus clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.